Alcohol-Related Endocannabinoid Release Can Depend on Intracellular Calcium

Calling alcohol a central nervous system depressant does not rule out calcium-dependent endocannabinoid release in a neuronal preparation. A review describes intracellular calcium mechanisms that help reconcile those observations.

A global drug label does not specify every cellular event

Pava and Woodward discuss brief alcohol exposure increasing intracellular calcium in selected preparations, including release from internal stores. Their account separates this cellular process from an overall description of alcohol’s behavioral effects.

Cultured neurons supplied a defined experiment

The review describes acute alcohol increasing anandamide and 2-AG in hippocampal cultures in a calcium-dependent manner, with reduced presynaptic glutamate release. The findings concerned a specified preparation and exposure; they did not measure every brain region or demonstrate an identical response throughout a living organism.

Mechanistic detail prevents an apparent contradiction

A local increase in a signaling intermediate can contribute to reduced neurotransmitter release. It need not imply global excitation or disprove depressant behavioral effects. The experiment also did not administer cannabis: it investigated endogenous cannabinoid signaling after alcohol. Extending the result to a person’s cognition or to THC–alcohol co-use requires evidence at those levels rather than inference from the cellular label alone.

Related reading: Alcohol–Endocannabinoid Reviews Need to Keep Stages of Dependence Separate.

Research cited

Pava MJ, Woodward JJ. A Review of the Interactions between Alcohol and the Endocannabinoid System: Implications for Alcohol Dependence and Future Directions for Research (2012). The experiments discussed here are described through this supplied review.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Four-Day Session Washout Was Not Four Days of Cannabis Abstinence

The interval between experimental sessions should not be mistaken for verified cannabis abstinence. In a heavy-user study, participants could continue their usual cannabis routine despite a minimum four-day interval between treatments. The instructions defined the exposure history Ramaekers and colleagues allowed usual cannabis smoking during the study period. Participants were…

Spread the love

Read Article: A Four-Day Session Washout Was Not Four Days of Cannabis Abstinence

Booster Alcohol Doses Changed What a Cannabis Cross-Tolerance Study Tested

Maintaining alcohol concentrations with repeated booster doses tests a different exposure pattern from a single drink followed by falling concentrations. That difference mattered in a study of heavy cannabis users. The protocol aimed to sustain exposure Ramaekers and colleagues targeted steady alcohol concentrations across several hours, using booster doses as…

Spread the love

Read Article: Booster Alcohol Doses Changed What a Cannabis Cross-Tolerance Study Tested

The Primate THC Study Did Not Directly Measure Drug Metabolism as a Tolerance Mechanism

A behavioral pattern consistent with receptor adaptation does not independently rule out pharmacokinetic contributions. A primate study explicitly states that drug metabolism and disposition were not assessed. The behavioral comparison supported a receptor hypothesis McMahon found different degrees of tolerance and cross-tolerance among THC and synthetic cannabinoid agonists. The pattern…

Spread the love

Read Article: The Primate THC Study Did Not Directly Measure Drug Metabolism as a Tolerance Mechanism

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us